Adam Feuerstein @adamfeuerstein now
$PBYI neratinib extenet study gets mediocre review from discussant. Small benefit but toxic.
$ONTY — I’ll write w/ more detail later but updated ‘380 data look good. More responses, including in the brain + no Gr3 diarrhea
Folks go to Bloomberg Report, Says CyberArk Software Most Sophisticated ,,
Investor Business Daily
The Israeli software maker, whose customers include banks and retailers in 65 countries, focuses on protecting businesses from undetected cyber threats that get inside their network perimeter.
CyberArk scores high ratings all around, including a 98 for Earnings Per Share and Relative Strength. A1.5 up-down volume ratio and a B+ Accumulation/Distribution Rating indicate demand for shares, as well as net buying by mutual funds.
CyberArk Announces Strong Fourth Quarter and Full Year 2014 Results
Fourth quarter total revenue of $36.3 million increases 81% year-over-year
Full Year 2014 total revenue of $103.0 million increases 56% year-over-year
Market Research Media
Cyber Security Market for 2015 - $65.5 Billion
Can Google It
MD Anderson President Ron DePinho, M.D., said:
Genetically engineering our patients’ immune-system T cells to efficiently attack and destroy cancer cells represents one of the most exciting approaches with curative potential in oncology today. We believe coupling MD Anderson’s unique CAR T cell approach with the powerful technologies of ZIOPHARM and Intrexon will allow us to build T cells that hit cancer harder, with greater precision, under tighter control and with potentially fewer side effects for patients. This agreement ranks as one of MD Anderson’s most substantial collaborations and will provide significant resources to fuel its mission of Making Cancer History
Investor Business Daily
Zacks By Zacks Equity Research
1 hour ago
Estimates for SGYP have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks
By Jim Cramer
Jul 20, 2015 | 01:00 AM EDT
I am making a case for $150 for Netflix, it's the opportunity -- the total addressable market is just too great and just getting started.
Wall Street -- CyberArk Will be One Of Wall Streets Fastest Growing Co'sWall Street